Analyzing multiple photos from across an oncology patient’s course of treatment with AI may be an even better predictor of survival than a single photo alone, a new Mass General Brigham study found.
Researchers behind FaceAge, which uses AI to forecast a person’s biological age, analyzed two photographs from each of 2,279 patients with cancer, taken at different time points during care, according to the April 28 study in Nature Communications.
“Deriving a Face Aging Rate from multiple, routine facial photographs allows for near real-time tracking of an individual’s health,” said co-senior and corresponding author Raymond Mak, MD, a radiation oncologist and faculty member in the AI in Medicine program at Somerville, Mass.-based Mass General Brigham, in a news release. “Our study suggests that measuring FaceAge over time may refine personalized treatment planning, improve patient counseling, and help guide the frequency and intensity of follow-up in oncology.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
